![Michael Tolpa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael J.
Tolpa is Treasurer & Director at Sanofi AATD, Inc. since 2024 and Treasurer at Provention Bio, Inc. since 2023.
Formerly, Mr. Tolpa was Treasurer at Blueprint Medicines Corp.
and Treasurer at Translate Bio, Inc.
Postes actifs de Michael Tolpa
| Sociétés | Poste | Début |
|---|---|---|
| INHIBRX, INC. | Directeur/Membre du Conseil | 30/05/2024 |
| PROVENTION BIO, INC. | Treasurer | 27/04/2023 |
Anciens postes connus de Michael Tolpa
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Treasurer | - |
| BLUEPRINT MEDICINES CORPORATION | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
